Skip to main content
Live · TradingView
Back to the NewsWire

WHBL

Published September 14, 2026

Definium's LSD -based drug lowers anxiety in new late-stage trial, shares soar - WHBL

Read the full story at WHBL

By Kamal Choudhury and Puyaan Singh Sept 14 (Reuters) - Definium Therapeutics said its LSD -based treatment reduced symptoms of generalized anxiety.

Surfaced by 2 Google Alerts

  • LSD
  • Psychedelic biotech